rs2297084

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000507.4(FBP1):​c.705+14C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.504 in 1,610,456 control chromosomes in the GnomAD database, including 206,952 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.51 ( 19869 hom., cov: 33)
Exomes 𝑓: 0.50 ( 187083 hom. )

Consequence

FBP1
NM_000507.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -0.879

Publications

11 publications found
Variant links:
Genes affected
FBP1 (HGNC:3606): (fructose-bisphosphatase 1) Fructose-1,6-bisphosphatase 1, a gluconeogenesis regulatory enzyme, catalyzes the hydrolysis of fructose 1,6-bisphosphate to fructose 6-phosphate and inorganic phosphate. Fructose-1,6-diphosphatase deficiency is associated with hypoglycemia and metabolic acidosis. [provided by RefSeq, Jul 2008]
FBP1 Gene-Disease associations (from GenCC):
  • fructose-1,6-bisphosphatase deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, PanelApp Australia, Genomics England PanelApp, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 9-94606801-G-A is Benign according to our data. Variant chr9-94606801-G-A is described in ClinVar as Benign. ClinVar VariationId is 256324.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.622 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FBP1NM_000507.4 linkc.705+14C>T intron_variant Intron 5 of 6 ENST00000375326.9 NP_000498.2
FBP1NM_001127628.2 linkc.705+14C>T intron_variant Intron 6 of 7 NP_001121100.1
FBP1XM_006717005.5 linkc.459+14C>T intron_variant Intron 5 of 6 XP_006717068.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FBP1ENST00000375326.9 linkc.705+14C>T intron_variant Intron 5 of 6 1 NM_000507.4 ENSP00000364475.5

Frequencies

GnomAD3 genomes
AF:
0.509
AC:
77319
AN:
151950
Hom.:
19854
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.478
Gnomad AMI
AF:
0.673
Gnomad AMR
AF:
0.633
Gnomad ASJ
AF:
0.680
Gnomad EAS
AF:
0.410
Gnomad SAS
AF:
0.430
Gnomad FIN
AF:
0.419
Gnomad MID
AF:
0.545
Gnomad NFE
AF:
0.515
Gnomad OTH
AF:
0.537
GnomAD2 exomes
AF:
0.517
AC:
127174
AN:
246200
AF XY:
0.511
show subpopulations
Gnomad AFR exome
AF:
0.475
Gnomad AMR exome
AF:
0.698
Gnomad ASJ exome
AF:
0.659
Gnomad EAS exome
AF:
0.398
Gnomad FIN exome
AF:
0.430
Gnomad NFE exome
AF:
0.514
Gnomad OTH exome
AF:
0.528
GnomAD4 exome
AF:
0.503
AC:
733738
AN:
1458388
Hom.:
187083
Cov.:
39
AF XY:
0.501
AC XY:
363778
AN XY:
725448
show subpopulations
African (AFR)
AF:
0.483
AC:
16131
AN:
33424
American (AMR)
AF:
0.696
AC:
30808
AN:
44296
Ashkenazi Jewish (ASJ)
AF:
0.658
AC:
17169
AN:
26090
East Asian (EAS)
AF:
0.391
AC:
15477
AN:
39622
South Asian (SAS)
AF:
0.434
AC:
37386
AN:
86088
European-Finnish (FIN)
AF:
0.426
AC:
22708
AN:
53298
Middle Eastern (MID)
AF:
0.545
AC:
2952
AN:
5418
European-Non Finnish (NFE)
AF:
0.504
AC:
559692
AN:
1109916
Other (OTH)
AF:
0.522
AC:
31415
AN:
60236
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
17750
35501
53251
71002
88752
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
16188
32376
48564
64752
80940
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.509
AC:
77376
AN:
152068
Hom.:
19869
Cov.:
33
AF XY:
0.506
AC XY:
37575
AN XY:
74324
show subpopulations
African (AFR)
AF:
0.478
AC:
19804
AN:
41474
American (AMR)
AF:
0.633
AC:
9679
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.680
AC:
2359
AN:
3470
East Asian (EAS)
AF:
0.410
AC:
2110
AN:
5142
South Asian (SAS)
AF:
0.431
AC:
2076
AN:
4822
European-Finnish (FIN)
AF:
0.419
AC:
4428
AN:
10576
Middle Eastern (MID)
AF:
0.541
AC:
158
AN:
292
European-Non Finnish (NFE)
AF:
0.515
AC:
35016
AN:
67972
Other (OTH)
AF:
0.536
AC:
1134
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1998
3996
5995
7993
9991
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
674
1348
2022
2696
3370
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.541
Hom.:
4153
Bravo
AF:
0.525
Asia WGS
AF:
0.433
AC:
1506
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Fructose-biphosphatase deficiency Benign:3
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Aug 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
0.052
DANN
Benign
0.67
PhyloP100
-0.88
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2297084; hg19: chr9-97369083; COSMIC: COSV64688692; COSMIC: COSV64688692; API